Buscar

Filtros actuales:


Comenzar nueva busqueda
Añadir filtros:

Usa los filtros para afinar la busqueda.


Resultados 1-10 de 13.
Resultados por ítem:
Vista previaFecha de publicaciónTítuloAutor(es)Acceso
Tesis Muriel Serrano, Javier.pdf.jpg26-jul-2019Tratamiento del trastorno por consumo de opioides de prescripción, en pacientes con dolor crónico no oncológico: efectividad, seguridad y marcadores farmacogenéticosMuriel, Javier
Clinical prediction of opioid use disorder in chronic pain patients. A cohort-retrospective study with a pharmacogenetic approach.pdf.jpg12-abr-2024Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach
Escorial, Mónica; Muriel, Javier; Agulló, Laura; Zandonai, Thomas; Margarit, César; Morales, Domingo; Peiró, Ana
Oxycodonenaloxone - naloxone versus tapentadol in real-world chronic non-cancer pain management.an observational and pharmacogenetic study.pdf.jpgjun-2022Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study
Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana
Long-term deprescription in chronic pain and opioid use disorder patients. Pharmacogenetic and sex differences.pdf.jpg18-nov-2022Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences
Muriel, Javier; Escorial, Mónica; Margarit, César; Barrachina, Jordi; Carvajal, Cristian; Morales, Domingo; Peiró, Ana
CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder. A Naturalistic Study with Extreme Phenotype Analysis.pdf.jpg3-jul-2023CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis
Ballester, Purificación; Espadas, Cristina; Almenara, Susana; Barrachina, Jordi; Muriel, Javier; Ramos, Enrique; Toral, Natalia; Belda, César; Peiró, Ana
CYP2D6 phenotypes and opioid metabolism. the path to personalised analgesia.pdf.jpgabr-2022CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesiaBallester, Purificación; Muriel, Javier; Peiró, Ana
The challenge of detecting adverse events in adults with autism.pdf.jpgmay-2021The challenge of detecting adverse events in adults with autism spectrum disorder who have intellectual disability
Ballester, Purificación; Espadas, Cristina; Londoño, Ana C.; Almenara, Susana; Aguilar, Víctor; Belda, César; Pérez, Enrique; Muriel, Javier; Peiró, Ana
Gender based differences, pharmacogenetics and adverse events.pdf.jpgabr-2020Gender based differences, pharmacogenetics and adverse events in chronic pain management
Planelles, Beatriz; Margarit, César; Inda, María del Mar; Ballester, Purificación; Muriel, Javier; Barrachina, Jordi; Ajo Ferrer, Raquel; Esteban, maría Dolores; Peiró, Ana
Evaluation of agomelatine for the.pdf.jpgnov-2019Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability
Ballester, Purificación; Martínez, María José; Inda, María del Mar; Javaloyes, María Auxiliadora; Richdale, Amanda; Muriel, Javier; Belda, César; Toral, Natalia; Morales, Domingo; Fernández, Eduardo; Peiró, Ana
Genetic Contribution in Low Back Pain A.pdf.jpgnov-2019Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study
Margarit, César; Roca, Reyes; Inda, María del Mar; Muriel, Javier; Ballester, Purificación; Moreu, Rocio; CONTE, LUCIA; Nuñez, Ángela; Morales, Domingo; Peiró, Ana